Patrizia Matarazzo Selected Research

Polyostotic Fibrous Dysplasia (McCune Albright Syndrome)

1/2018	Growth hormone-Insulin-like growth factor 1 axis hyperactivity on bone fibrous dysplasia in McCune-Albright Syndrome.
3/2016	Odontoiatric perspectives and osteonecrosis of the jaw as a possible adverse effect of bisphosphonates therapy in fibrous dysplasia and McCune-Albright syndrome.
1/2012	Combined treatment with bicalutamide and anastrozole in a young boy with peripheral precocious puberty due to McCune-Albright Syndrome.
5/2006	Genetics of McCune-Albright syndrome.
5/2006	Bisphosphonate treatment of bone fibrous dysplasia in McCune-Albright syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrizia Matarazzo Research Topics

Disease

5	Polyostotic Fibrous Dysplasia (McCune Albright Syndrome) 01/2018 - 05/2006
3	Fibrous Dysplasia of Bone 01/2018 - 05/2006
3	Precocious Puberty 01/2012 - 11/2004
2	Wasting Syndrome (Wasting Disease) 01/2020 - 01/2012
2	Hypoparathyroidism 01/2020 - 01/2014
2	Thyroid Nodule (Nodule, Thyroid) 11/2013 - 01/2011
2	Ovarian Cysts (Ovarian Cyst) 05/2006 - 05/2006
1	Diabetes Insipidus 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 12/2020
1	Hypocalcemia 01/2020
1	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 01/2020
1	Hyperphosphatemia 01/2020
1	Neoplasms (Cancer) 01/2020
1	Hydrocephalus (Hydrocephaly) 01/2020
1	Uniparental Disomy 10/2019
1	Hypertension (High Blood Pressure) 03/2018
1	Hypokalemia 03/2018
1	Liddle Syndrome 03/2018
1	Alkalosis 03/2018
1	Polydipsia 01/2018
1	Adenoma (Adenomas) 01/2018
1	Optic Nerve Diseases (Optic Neuropathy) 01/2018
1	Polyuria 01/2018
1	Inappropriate ADH Syndrome (SIADH) 01/2017
1	Heart Failure 01/2017
1	Hypovolemia 01/2017
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2017
1	Hyponatremia 01/2017
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017
1	Osteonecrosis (Kienbock's Disease) 03/2016
1	Anemia 08/2012
1	Hyperthyroidism 01/2012
1	Cushing Syndrome 01/2011
1	Hypopituitarism (Sheehan's Syndrome) 05/2010
1	Breast Neoplasms (Breast Cancer) 08/2007
1	Uterine Hemorrhage (Uterine Bleeding) 05/2006

Drug/Important Bio-Agent (IBA)

3	Growth Hormone (Somatotropin)IBA 01/2018 - 08/2007
2	Vasopressins (Vasopressin)IBA 01/2021 - 01/2017
2	Parathyroid Hormone (Parathormone)IBA 01/2020 - 01/2014
2	Teriparatide (Parathar)FDA Link 01/2020 - 01/2014
2	CalciumIBA 01/2020 - 01/2014
2	Phosphates (Orthophosphate)IBA 01/2020 - 01/2012
2	Diphosphonates (Bisphosphonates)IBA 03/2016 - 05/2006
2	Estrogens (Estrogen)FDA Link 05/2006 - 05/2006
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2020
1	Alkaline PhosphataseIBA 01/2020
1	CreatinineIBA 01/2020
1	SodiumIBA 01/2020
1	SaltsIBA 01/2020
1	calcium phosphateIBA 01/2020
1	Insulin-Like Growth Factor I (IGF-1)IBA 10/2019
1	AldosteroneIBA 03/2018
1	Triamterene (Dyrenium)FDA LinkGeneric 03/2018
1	Amiloride (Midamor)FDA LinkGeneric 03/2018
1	ReninIBA 03/2018
1	Insulin-Like PeptidesIBA 01/2018
1	Arginine Vasopressin (Argipressin)IBA 01/2018
1	Tolvaptan FDA Link 01/2017
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2017
1	ElectrolytesIBA 01/2017
1	conivaptan (Vaprisol)FDA Link 01/2017
1	Hypertonic SolutionsIBA 01/2017
1	Vitamin D FDA LinkGeneric 01/2014
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 11/2013
1	Human Growth Hormone (Saizen)FDA LinkGeneric 08/2012
1	Hemoglobins (Hemoglobin)IBA 08/2012
1	bicalutamide (Casodex)FDA LinkGeneric 01/2012
1	Androgen Receptors (Androgen Receptor)IBA 01/2012
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2012
1	Aromatase InhibitorsIBA 01/2012
1	4-(fluoromethyl)phenyl phosphate (FMPP)IBA 01/2012
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2011
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2011
1	Codon (Codons)IBA 05/2006
1	GonadotropinsIBA 05/2006
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 11/2004

Therapy/Procedure

9	Therapeutics 12/2020 - 05/2010
1	Total Parenteral Nutrition 01/2020
1	Duration of Therapy 05/2010